Liège-based pharmaceutical company Mithra, in partnership with Mayne Pharma Group, has announced the commercial launch of NextCellis, the first oral contraceptive based on a new estrogen, in Australia.
****** ********** ************* *** ** ******* ********** ** ********** ** ******* ********** ***** ************** * * * *********** **** ** **** ***** ****** ** ********** *** ** ***** ** ********** ** *********** ** ******* ********** * * **** ** **** ****** ****** ************** ** ****** ****** * * ***** ********** *****
******** *** ** ********** ***** ******* *** ** ***** **** * * ******* ** ********** ** ******* ** ******* ** ******* * ** ******** **** ** *********** ***********
** ******* *** ********** ********** *** ** ******* ****** **** *** ************** ***** ********* ************** *** * * ********* *** ************** ***** ********* ******* ** * * ***** ************** ** **** ********** **** ***** **** * ** **** ** ****** ************** * ***** ********
******************************
**** *** ******* *** ** ******* ** ******** ** ** ********** ******* ** ** ******* **************
“Certified food fanatic. Extreme internet guru. Gamer. Evil beeraholic. Zombie ninja. Problem solver. Unapologetic alcohol lover.”
More Stories
In six months, the presidential election results will shake the world
No finals for the Blues who beat Australia in Singapore
An environmentalist shouted “Allahu Akbar” to celebrate his victory in Leeds, England